BGB-DXP593

· BeiGene

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BGB-DXP593, covering 2022-03-17 to 2024-03-15. Get the full timeline:

Most recent: Clinical Trial Update: BGB-DXP604 Alone and in Combination With BGB-DXP593 in Healthy Participants [Phase 1]